Call 01483 459 659 or email uk.enquiries@enovis.com for assistance.
Alternatively, complete the form below and our team will be in touch.
Chronic pain and musculoskeletal conditions can be frustrating for patients and challenging for clinicians to manage. But recent research shows that extracorporeal shockwave therapy (ESWT) and photobiomodulation therapy (PBMT, or laser therapy) are delivering measurable relief in conditions ranging from low back pain to plantar fasciitis.
In this post, we break down the latest findings and what they mean for clinical practice.
Shockwave therapy has been used since the 1980s, originally for breaking down kidney stones. Today, it’s a proven option for treating musculoskeletal pain.
There are two main types:
Both work through mechanotransduction — using acoustic waves to trigger biochemical changes that promote pain relief and tissue healing.
Often called “cold laser” or “low-level laser therapy (LLLT),” PBMT uses light energy to stimulate cellular repair without causing thermal damage.
High-Intensity Laser Therapy (HILT) has emerged as a faster, deeper-reaching alternative to LLLT. Both forms of PBMT promote pain reduction, tissue healing, and improved function.
One study found that combining ESWT and PBMT for plantar fasciitis provided the best results, with a 90% reduction in pain scores and a 56% improvement in function — far outperforming either therapy alone.
The evidence is clear:
For physiotherapists, chiropractors, and rehab specialists, incorporating these modalities can enhance treatment protocols, improve patient satisfaction, and deliver long-term relief.
Enovis™ is a global medical technology company committed to creating better patient outcomes with innovative solutions like Chattanooga® shockwave devices and LightForce® therapy lasers.
👇Contact us via the form below for more information
👉Access full E-Book by clicking HERE
References available on request.
Alternatively, complete the form below and our team will be in touch.